We recommend that the authors use the check list provided by the journal.
□ Provide a covering letter stating the material has not been published previously, will not be submitted for publication elsewhere, and stating conflicts of interest of all listed authors, if any.
□ Ensure all listed authors have read the final manuscript and agree with the submission.
□ Include written permission from publishers to reproduce or adapt previously published illustrations or tables.
□ The manuscript must be typed in MS Word, with a 12-point font and double-spaced on A4 pages.
□ Article layout should follow this sequence: Title page, abstract and keywords, key message (≤70 words), graphical abstract (recommended), introduction, methods, results, discussion, acknowledgments, references, tables, figure legends, and figures in the original article.
□ All pages should be numbered consecutively starting with the title page.
□ Line numbers should be inserted consecutively starting with the title page.
□ Title page with article title, authors full name(s), degree and affiliation, running title (less than 10 words), address for correspondence (including telephone and e-mail address), funding, conflict of interests, author contribution (ORCiD number) and footnotes, if any.
□ Provide an abstract in a structured format for original articles and in an unstructured format for review articles (maximum of 300 words), and keywords as in MeSH.
□ References should be listed in a proper format. Check that all references listed in the references section are cited in the text and vice versa.
□ By reading the table title and any footnotes, the reader should be able to understand the main findings presented in the table without looking at the main text of the article.
□ By reading the figure legend, the reader should be able to understand the main findings presented in the figure without looking at the main text of the article.
□ Generic names are used for all drugs. Trade names are avoided.